PrimeRFP SCOUT · Federal Contract Recompete Brief

36C77021N0218Valbenazine 40mg ORAL CAP 30ct NDC — Neurocrine Biosciences, Inc

Public-record facts for this award are shown above. Open SCOUT for live scoring relative to your firm, watchlists, and capture workflow.

National Cmop Office (36C770)
Awarding office
Neurocrine Biosciences, Inc
Recipient
—
Estimated value
6505
PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Federal
Contract number36C77021N0218
Also listed as36C770-21-N-0218
AgencyNational Cmop Office (36C770)
Awarding officeNational Cmop Office (36C770)
Awarding agencyDepartment of Veterans Affairs (VA)
Funding agencyDepartment of Veterans Affairs (VA)
IncumbentNeurocrine Biosciences, Inc
UEIGMQSH4CZ7EC9
PSC6505

VALBENAZINE 40MG ORAL CAP 30CT NDC: 70370-2040-01 VALBENAZINE 80MG ORAL CAP 30CT NDC: 70370-1080-01) is a federal award for National Cmop Office (36C770) held by Neurocrine Biosciences, Inc. Estimated value —.

VALBENAZINE 40MG ORAL CAP 30CT NDC: 70370-2040-01 VALBENAZINE 80MG ORAL CAP 30CT NDC: 70370-1080-01)

Bonuses end Sept 30

Want the durability read on 36C77021N0218? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Explore more pipelines →

Frequently asked questions

What is contract 36C77021N0218?

36C77021N0218 (Valbenazine 40mg ORAL CAP 30ct NDC) is a National Cmop Office (36C770) award with an estimated value of —, currently held by Neurocrine Biosciences, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C770-21-N-0218?

36C770-21-N-0218 is the dashed form of PIID 36C77021N0218 (Valbenazine 40mg ORAL CAP 30ct NDC), held by Neurocrine Biosciences, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C77021N0218?

National Cmop Office (36C770) awarded 36C77021N0218 to Neurocrine Biosciences, Inc.

Who is the incumbent on 36C77021N0218?

Neurocrine Biosciences, Inc is the incumbent.

When does Neurocrine Biosciences, Inc’s 36C77021N0218 come up for recompete?

SCOUT tracks a period-of-performance end of an unstated date. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 36C77021N0218? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/36C77021N0218